By Y. Lares. Brenau University. 2018.
This chapter critically examines the litera- ture that suggests the individual’s culture makes a critical difference in pain behavior and management buy 100mg fildena otc impotence after 50. In the first buy fildena 100mg without prescription impotence in diabetics, samples were small and poorly obtained and science often took a back seat to stereotypes. The second stage was marked by greater interest in both theory and methodology, but the validity of the findings was still of- ten questionable. The third stage, which has recently emerged, is character- ized by greater sophistication, larger sample sizes and population distribu- tions, and closer attention to psychosocial factors which may mediate the results. For reasons of convenience, most early studies of pain and culture took place in the laboratory. Typically, small numbers of persons from one cul- tural group were compared to small numbers of persons from one or two other groups, and sweeping generalizations were made. Wolff (1985) sum- marized a typical conclusion: Scandinavians are tough and stoic with a high tolerance to pain; the British are more sensitive but, in view of their ingrained “stiff, upper lip,” do not com- plain when in pain; Italians and other Mediterranean people are emotional and overreact to pain; and Jews both overreact to pain and are preoccupied with pain and suffering as well as physical health. To draw that conclu- sion, they asked questions about attitudes to pain and tested pain reactivity in American-born women from four different ethnic groups: Yankee (Protes- tants of British descent whose parents and grandparents were born in the United States), Irish, Italian, and Jewish (the last three born of parents who emigrated to the United States from Europe). There were sizeable differ- ences in pain tolerance (the level at which participants indicated that the pain had reached the maximum level they wished to experience). The Yan- kee and Jewish subjects withstood significantly higher values than the Ital- ians, with the Irish at an intermediate level. ETHNOCULTURAL VARIATIONS IN PAIN 157 These conclusions about the pain reactions of Old Americans, Jews, Ital- ians, and Irish are interesting but unwarranted. More importantly, 15 Massachusetts homemakers per sample hardly allow one to draw generalizations about either the atti- tudes or the pain responses of an ethnic or cultural group. Individuals vary enormously in their response to experimentally induced pain, and the dif- ferences between groups, even in large studies, is generally quite modest in comparison to the intergroup variability. Zborowski’s book Peo- ple in Pain, published in 1969, is often cited because of its early examination of how culture might shape the pain response. His conclusions—Old Ameri- cans are stoic, Italians loudly demand pain relief, and Jews seek relief but worry about the future implications of their disorder—all came from staff re- ports at a single New York Veterans Administration hospital. Likewise, Zola’s (1966) study of interethnic differences in pain reporting and attitudes was based on interviews with patients at various outpatient clinics at the Massachusetts General Hospital. He focused on 63 Italians and 81 Irish new admissions of comparable age, education, and social class. The study found that the Irish were markedly more inclined to locate their problem in the eye, ear, nose, or throat but were also more likely to say that the problem was not painful (“It was more a throbbing than a pain. In contrast, the Italians tended to report diffuse discomfort, pre- sented more symptoms, had complaints in more bodily locations, and indi- cated that they had more kinds of dysfunctions. Zola speculated that “Italian and Irish ways of communicating illness may reflect major values and preferred ways of handling problems within the culture itself” and could be understood in terms of generalized expres- siveness. So, for the Italians, the complaints may relate to “their expansive- ness so often [seen] in sociological, historical, and fictional writing”—a “well seasoned, dramatic emphasis to their lives. It was as if “life was black and long- suffering and the less said the better. Lipton and Marbach (1984) presented a scholarly review of the literature on ethnicity and pain that had been collected until the early 1980s, noting its many inadequacies. Sometimes, responses from patients were examined in individual ethnic groups (e. Some studies focused deliberately on pain, whereas others included 158 ROLLMAN a few pain-related questions as part of a broader study of health beliefs and practices. Some used a short questionnaire, whereas others relied on inter- views or caretaker impressions. Lipton and Marbach proposed a model based upon three major areas of the pain experience. First was the physical experience—its intensity, qual- ity, duration, and location—and the way in which the patient describes these sensations to others. They introduced three subcategories here: cognitive in- terpretation (the interpretation and evaluation of the perceived pain), emo- tional responses (fear, anxiety, or depression and whether it is expressed openly or covertly), and function (how the pain affects social interaction and daily activities). The third area was medical intervention, dealing with the individual’s action in response to pain and role as a pain patient (com- pliant and trusting or challenging and uncooperative).
Oral intake is allowed fildena 25 mg for sale erectile dysfunction treatment side effects, but wounds should be kept clean to avoid any graft shearing and infection cheap fildena 25 mg otc erectile dysfunction doctor los angeles. Stage Two: Second Look and Autografting Approximately 1 weeklater (between 4 and 7 days after excision and homograft- ing), the patient returns to the operating room for definitive wound closure. If homo- grafts are well adherent to the wound bed and there are signs of revasularization, the wound is ready for skin autografting. When the homografts are found to be loose and nonadherent, facial wounds need to be excised and homografted again. In this case, patients return 4 days following the second stage for a further inspec- tion. If the wound bed is vital, epinephrine-soaked (1:10,000) Telfa dressings are applied. When grafts need to match nonburned or healed face areas, the scalp should be used. When the entire face must be grafted, the scalp does not provide enough quantity of skin graft. The skin grafts must be obtained from the same donor site to graft the entire face with the same quality of skin to render a good color match all over the face. It is not acceptable to obtain skin from the scalp and elsewhere at the same time. This will inevitably leave an area of color mis- match that will be not accepted by the patient. When the scalp is used, the size and form of the skin grafts should be drawn on the surface before any subcutane- ous infusion is applied. Four good-sized pieces of skin autografts can usually be obtained from the scalp: One anterior piece from ear to ear posterior to the hair line One posterior piece from vertex to the occipital region Two lateral pieces from the retroauricular region to the neck The scalp is infiltrated with epinephrine-containing normal saline (1:200,000) until large flat areas are obtained. The larger guards should be used to obtain good-quality grafts with appropri- ate width. The assistants should hold the head and the anesthetist control the ET tube while the harvesting is in process. Pressure must be exercised on the opposite part of the head to maintain the countertraction. Two assistants are necessary, main- taining pressure on the periphery of the skull to leave the entire area around the top of the scalp ready for harvest. After harvesting, epinephrine-soaked (1:10,000) Telfa dressings are immediately applied and left in place for 10 min. The scalp is then dressed in the standard fashion (either Biobrane or Acticoat dressings). When the entire face must be grafted, the scalp will not provide enough skin grafts. An alternative donor site is chosen (the backprovide large amounts of good quality skin), and all skin grafts necessary to graft the entire face are taken from the same area to provide excellent color match. It is important to preserve the donor site that might be used for face grafting in order to provide the best quality of skin. A master plan is developed shortly after admission, and, if at all possible, the donor area to be used for face burns is spared. Donor sites are also infiltrated with large amounts of normal saline with epinephrine and powered dermatomes are used. The manual Padgett dermatome is the best instrument to obtain skin for cheeks and forehead, but it is cumbersome and difficult to use. Common thicknesses for face burns skin grafting are as follows: Eyelids: 16/1000 inch Children (all other areas): 14–18/1000 inch Adults (all other areas): 18–21/1000 inch The grafts are then carefully stitched into place with 4/0 and 5/0 plain catgut or Vycril rapide. Bolsters are used on the eyelids, but the rest of the face is left exposed. Grafts should be stitched with slight tension to return grafts to their normal physi- cal properties and avoid wrinkles.
Piantanida fildena 100 mg with mastercard how to treat erectile dysfunction australian doctor, MD discount 150mg fildena free shipping impotence of organic origin icd 9, Director, Primary Care Sports Medicine, DeWitt Army Hospital, Ft. Porter, Orthopaedic Service, William Beaumont Army Medical Center, Texas Tech UHS, El Paso, Texas Joel Press, MD, FACSM, Medical Director, Center for Spine, Sports, and Occupational Rehabilitation, Rehabilitation Institute of Chicago, Chicago, Illinois David E. Prior, DO, Director, Sports Medicine, Department of Family Medicine, Darnall Army Community Hospital, Fort Hood, Texas Scott W. Pyne, MD, Team Physician & Director of Sports Medicine, US Naval Academy, Annapolis, Maryland Christopher B. Ranney, MD, Department of Family Practice, Offut Air Force Base, Nebraska Brian V. Reamy, MD, Associate Professor and Chair, Department of Family Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland John P. Reasoner, MD, Member, USA Boxing Sports Medicine Committee, Clinic Director, Emergicare Medical Clinic, Colorado Springs, Colorado Jennifer L. Reed, MD, Assistant Professor, PM&R, Eastern Virginia Medical School, Norfolk, Virginia John C. Richmond, MD, Professor, Orthopedic Surgery, Tufts University School of Medicine, Chairman, Department of Orthopedic Surgery, New England Baptist Hospital CONTRIBUTORS xvii Nancy E. Rolnik, Sports Medicine Fellow, Kaiser Permanente, Fontana, California Aaron Rubin, MD, Staff Physician and Partner, Southern California Permanente Medical Group, Program Director, Kaiser Permanente Sports Medicine Fellowship Program, Kaiser Permanente Department of Family Medicine, Fontana, California Anthony A. Schepsis, MD, Associate Professor of Orthopedic Surgery, Director of Sports Medicine, Boston University Medical Center, Boston, Massachusetts Leanne L. Seeger, MD, FACR, Professor and Chief, Musculoskeletal Imaging, Medical Director, Outpatient Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California Peter H. Louis University Family Practice Residency Program, 375th Medical Group, Scott Air Force Base, Illinois Kate Serenelli, MS, ATC, CSCS, Staff Athletic Trainer, Department of Athletics, University of Virginia, Charlottesville, Virginia Craig K. Seto, MD, Assistant Professor, Family Medicine, University of Virginia Health System, Charlottesville, Virginia Michael Shea, MD, Sports Medicine Fellowship Program, Moses Cone Health System, Greensboro, North Carolina Jay Smith, MD, Associate Professor, Physical Medicine & Rehabilitation, Mayo College of Medicine, Rochester, Minnesota Carolyn M. Sofka, MD, Assistant Professor of Radiology, Weill Medical College of Cornell University, Assistant Attending Radiologist, Hospital for Special Surgery, New York, New York Rebecca Spaulding, MD, Sports Medicine Fellowship Program, Moses Cone Health System, Greensboro, North Carolina Mark B. Stephens, MD, MS, Staff Family Physician, Medical Director, Flight Line Clinic, Naval Hospital, Sigonella, Italy, Associate Professor of Family Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland David Stewart, MD, Sports Medicine Fellow, Muses Cone Health System, Greensboro, North Carolina Dean C. Taylor, MD, Director, US Army Joint and Soft Tissue Trauma Center Fellowship, Head Team Physician, United States Military Academy, West Point, New York John Tobey, MD, Spine and Sports Fellow, Department of Rehabilitation Medicine, University of Colorado Health Science Center, Aurora, Colorado John Turner, MD, CAQSM, Assistant Professor, Department of Family Medicine, Indiana University, Indianapolis, Indiana Winston J. Warme, MD, Chief, Orthopedic/Rehabilitation Service, Program Director, Orthopedic Surgery Residency, William Beaumont Army Medical Center, Texas Tech UHSC, El Paso, Texas Charles W. Webb, DO, Director of Sports Medicine, Department of Family Practice, Martin Army Community Hospital, Ft. Benning, Georgia Brian Whirrett, MD, Sports Medicine Fellow, University of Washington, Seattle, Washington DC Russell D. White, MD, Clinical Associate Professor, Department of Family Medicine, University of South Florida College of Medicine, Florida Institute of Family Medicine, P. Wilckens, MD, Assistant Clinical Professor of Orthopedics, Johns Hopkins Bayview Medical Center, Baltimore, Maryland xviii CONTRIBUTORS Cynthia M. Williams, DO, MEd, Assistant Professor of Family Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland Pamela M. Williams, Assistant Professor of Family Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland Tory Woodard, MD, Chief Resident, Department of Family Medicine, Malcolm Grow Air Force Medical Center, Andrews Air Force Base, Maryland David C. Young, MD, Sports Medicine, The Permanente Medical Group, Department of Orthopedics, South San Francisco, California Joseph J. Zuback, Orthopaedic Service, William Beaumont Army Medical Center, Texas Tech UHS, El Paso, Texas PREFACE In the spring of 1993, primary care sports physicians across the country were scrambling to identify good resources to prepare for the first examination for a Certificate of Added Qualification in Sports Medicine. This examination was co-sponsored by the American Boards of Family Practice, Internal Medicine, Pediatrics, and Emergency Medicine. At review courses a common theme was that at that time, there was no identifiable source that reliably identified the dis- cipline of sports medicine, let alone a good review book or study guide. Since that time, of course, there have been a number of excellent books published in the field of primary care sports medicine. At the Annual Meeting of the American College of Sports Medicine in 2002, Darlene Cook of McGraw-Hill approached me about a new line of textbooks that their company was developing called Just the Facts.
This model is feasible purchase 100mg fildena mastercard erectile dysfunction drugs and alcohol, stepped buy fildena 50 mg otc erectile dysfunction pumps review, interdisciplinary, multifaceted, and lends itself to evaluation and improvement. It optimally combines public health perspective with patient- centered care based on individual patient needs. These linkages between public health and individual patient approaches are made with carefully planned health information systems along with an emphasis on primary care. References 1 Writer JV, DeFraites RF, Brundage JF: Comparative mortality among US military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. May 2002 Gulf War Veterans Information System Briefing For: National Gulf War Resource Center. Engel/Jaffer/Adkins/Riddle/Gibson 120 26 Lin EH, Katon W, Von Korff M, Bush T, Lipscomb P, Russo J, Wagner E: Frustrating patients: Physician and patient perspectives among distressed high users of medical services. A review of the scientific evidence on prevention after disability begins. Adequacy of the Comprehensive Clinical Evaluation Program: A Focused Assessment. Engel Department of Psychiatry Uniformed Services University of the Health Sciences 4301 Jones Bridge Road, Bethesda, MD 20814-4799 (USA) Tel. Basel, Karger, 2004, vol 25, pp 123–137 Opioid Effectiveness, Addiction, and Depression in Chronic Pain Paul J. Raja Division of Pain Medicine, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Opioid responsiveness is influenced by patient-centered characteristics, including a predisposition to opioid side effects, psycholog- ical distress, and opioid use history; pain-centered characteristics, which involve the tempo- ral pattern, rapidity of onset, severity, and type of pain; and drug-centered characteristics relating to the impact of specific types of opioids on specific patients. Thus, opioid doses should be titrated to achieve a favorable balance between analgesia and adverse effects. Opioid therapy can be enhanced through the adjunct administration of agents such as NMDA antagonists, calcium channel blockers, clonidine, and even low-dose opioid antagonists. Controversy exists over 1) the long-term use of opioids for non-cancer pain, and patients receiving opioids for long periods must be monitored carefully for signs of addictive and aberrant behavior, 2) the impact of opioid therapy on emotional depression in patients with chronic pain, and 3) whether opioid therapy causes cognitive impairment in the elderly. Our ability to determine the validity of such assertions and the exact role of opioids in the treat- ment of chronic pain will benefit from further study. Karger AG, Basel Introduction One third of the United States population will experience chronic pain. In fact, chronic pain is the most common cause of long-term disability in the United States and partially or totally disables nearly 50 million people. Among the therapeutic options for treatment of chronic pain, the use of opioids remains a viable choice. Research into opioid pharmacology over the past 20 years has expanded our knowledge of the mechanism of action of opioids. Many studies on patients with cancer pain have provided insight into the clinical pharmacology of opioids. Research findings support the idea that the pharmacokinetic and pharmacodynamic principles of opioids in cancer patients with pain hold true in patients with chronic, nonmalignant pain. While the use of opioids for chronic cancer pain is widely accepted, the efficacy and role of opioids in the management of chronic noncancer pain has been intensely debated. Opponents argue that there is no place for opioids in the treatment of chronic benign pain and opine that narcotics are a major impedi- ment to the successful treatment of chronic pain. This view is largely based on concerns regarding tolerance, physical dependence, addiction, and adverse affective and cognitive side effects. Much of this debate has occurred till recent years in the absence of randomized clinical trials. Although several recent studies have demonstrated that chronic pain, including neuropathic pain states such as postherpetic neuralgia, is responsive to opioids, these studies have followed patients for relatively short periods of 2 months or less. More careful studies of the long-term efficacy of opioids are needed to determine if tolerance to the analgesic effects of opioids limits its usefulness for long-term therapy. Opioid Effectiveness The appropriate use of opioids in the management of chronic pain demands individualization. That is, one opioid does not ‘fit all’ patients with a certain type of pain. In addition, we lack a mechanistic approach that would guide the management of chronic pain states with specific opioids. The goal in the management of a patient’s pain with opioids is to achieve an optimal bal- ance between the drug’s analgesic effects and any associated adverse effects.
9 of 10 - Review by Y. Lares
Votes: 293 votes
Total customer reviews: 293